
- Oncology NEWS International Vol 15 No 7
- Volume 15
- Issue 7
HNPCC Pts May Reject Prophylactic Subtotal Colectomy
People with hereditary nonpolyposis colorectal cancer (HNPCC), are willing to consider the pros and cons of prophylactic subtotal colectomy to manage their disorder, but still have strong concerns about the procedure
AMELIA ISLAND, FloridaPeople with hereditary nonpolyposis colorectal cancer (HNPCC), are willing to consider the pros and cons of prophylactic subtotal colectomy to manage their disorder, but still have strong concerns about the procedure, according to a study presented at the American Psychosocial Oncology Society (APOS) Third Annual Conference (abstract P12-3).
Karen Hurley, PhD, Department of Psychiatry and Behavioral Sciences, Memorial Sloan-Kettering Cancer Center, interviewed 11 people with HNPCC about their willingness to undergo prophylactic subtotal colectomy: Fewer than half (45.5%) said they would consider the surgery even in the event of a diagnosis of colorectal cancer. A smaller percentage, 18.2%, said they would consider it even without a cancer diagnosis, and 36% said they would not consider it at all. For most (63.6%), not needing an annual colonoscopy was not considered enough of an incentive to have the surgery. Slightly more than half had never heard about the prophylactic surgery before their interview. They were more likely to know about it if they had already received a cancer diagnosis. "People with HNPCC should be considering the option of prophylactic subtotal colectomy before they get hit with a cancer diagnosis, so they can make informed and reasoned choices," Dr. Hurley said.
Articles in this issue
over 19 years ago
High-Quality Screening Colonoscopy Priority for GI Docsover 19 years ago
Genentech Seeks Expanded Use of Avastin in Breast Cancerover 19 years ago
Denosumab Suppresses Bone Resorption in Breast Ca Metsover 19 years ago
FDA Approves Priority Review of Merck's Zolinza (Vorinostat)over 19 years ago
FDA Approves Revlimid for Myeloma Rxover 19 years ago
Real-Time RT Planning, Delivery in the Bronxover 19 years ago
Phase III Trial of Enzastaurin for NHL Patients Initiatedover 19 years ago
Racial Disparities in Prostate Ca RecurrenceNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.


















































































